Evaluating a Digital Toolkit for IPV (NCT07600307) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluating a Digital Toolkit for IPV
792 participantsStarted 2026-12-01
Plain-language summary
The study evaluates a web-based digital toolkit designed to screen for intimate partner violence (IPV), post-traumatic stress disorder (PTSD), and related mental health concerns within opioid treatment programs. Providers use the toolkit during routine care with patients receiving treatment for opioid use disorder. The study examines how the toolkit is implemented into clinic workflows and whether its use improves detection, referral, and patient outcomes.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria for all participants:
* Age 18 and older
* Able to understand and sign a consent form in English
Inclusion criteria for OTPs:
* Current experience working in one of the three opioid treatment clinics serving as a recruitment site for this study
* Health care professional training (e.g., social worker, counselor, physician, psychologist, nurse practitioner)
Exclusion criteria for OTPs:
\- None
Inclusion criteria for patients with OUD:
* Report opioids as their primary substance of use for which they are seeking treatment
* Receive treatment at one of the three opioid treatment clinics serving as a recruitment site for this study
Exclusion criteria for patients with OUD:
* An acute medical problem requiring inpatient treatment (e.g., detoxification)
* Incarceration at the time of the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Proportion of patients who receive screening
Timeframe: From enrollment until the end of study participation at (up to) 35 months
2
Proportion of patients screened positive for intimate partner violence
Timeframe: From enrollment until the end of study participation at (up to) 35 months
3
Proportion of intimate partner violence-positive patients who receive recommended or referred services
Timeframe: From enrollment until the end of study participation at (up to) 35 months
4
Proportion of patients retained on MOUD following intimate partner violence and mental health screening
Timeframe: From enrollment until the end of study participation at (up to) 35 months